Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)

Paolo Gisondi; Alice B. Gottlieb; Boni Elewski; Matthias Augustin; Sandy McBride; Tsen Fang Tsai; Christine de la Loge; Frederik Fierens; José M. López Pinto; Nicola Tilt; Mark Lebwohl

doi:10.1007/s13555-023-00934-y

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)

Paolo Gisondi, Alice B. Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen Fang Tsai, Christine de la Loge, Frederik Fierens, José M. López Pinto, Nicola Tilt, Mark Lebwohl

Research output: Contribution to journal › Comment/debate

Abstract

In the original publication, the supplementary material was incorrectly formatted prior to publication. The publisher apologises for the errors that were introduced. The supplementary material has been replaced with the corrected version and these errors have been fixed. The original article has been corrected.

Original language	English
Pages (from-to)	1389-1390
Number of pages	2
Journal	Dermatology and Therapy
Volume	13
Issue number	6
DOIs	https://doi.org/10.1007/s13555-023-00934-y
State	Published - Jun 2023

Access to Document

10.1007/s13555-023-00934-y

Fingerprint

Dive into the research topics of 'Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)'. Together they form a unique fingerprint.

Cite this

Gisondi, P., Gottlieb, A. B., Elewski, B., Augustin, M., McBride, S., Tsai, T. F., de la Loge, C., Fierens, F., López Pinto, J. M., Tilt, N., & Lebwohl, M. (2023). Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4). Dermatology and Therapy, 13(6), 1389-1390. https://doi.org/10.1007/s13555-023-00934-y

Gisondi, Paolo ; Gottlieb, Alice B. ; Elewski, Boni et al. / Publisher Correction : Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4). In: Dermatology and Therapy. 2023 ; Vol. 13, No. 6. pp. 1389-1390.

@article{eb98a6cfb09844b1888cb0dcebac899d,

title = "Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)",

abstract = "In the original publication, the supplementary material was incorrectly formatted prior to publication. The publisher apologises for the errors that were introduced. The supplementary material has been replaced with the corrected version and these errors have been fixed. The original article has been corrected.",

author = "Paolo Gisondi and Gottlieb, {Alice B.} and Boni Elewski and Matthias Augustin and Sandy McBride and Tsai, {Tsen Fang} and {de la Loge}, Christine and Frederik Fierens and {L{\'o}pez Pinto}, {Jos{\'e} M.} and Nicola Tilt and Mark Lebwohl",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = jun,

doi = "10.1007/s13555-023-00934-y",

language = "English",

volume = "13",

pages = "1389--1390",

journal = "Dermatology and Therapy",

issn = "2190-9172",

publisher = "Springer Verlag",

number = "6",

}

Gisondi, P, Gottlieb, AB, Elewski, B, Augustin, M, McBride, S, Tsai, TF, de la Loge, C, Fierens, F, López Pinto, JM, Tilt, N & Lebwohl, M 2023, 'Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)', Dermatology and Therapy, vol. 13, no. 6, pp. 1389-1390. https://doi.org/10.1007/s13555-023-00934-y

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4). / Gisondi, Paolo; Gottlieb, Alice B.; Elewski, Boni et al.
In: Dermatology and Therapy, Vol. 13, No. 6, 06.2023, p. 1389-1390.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Publisher Correction

T2 - Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4)

AU - Gisondi, Paolo

AU - Gottlieb, Alice B.

AU - Elewski, Boni

AU - Augustin, Matthias

AU - McBride, Sandy

AU - Tsai, Tsen Fang

AU - de la Loge, Christine

AU - Fierens, Frederik

AU - López Pinto, José M.

AU - Tilt, Nicola

AU - Lebwohl, Mark

PY - 2023/6

Y1 - 2023/6

N2 - In the original publication, the supplementary material was incorrectly formatted prior to publication. The publisher apologises for the errors that were introduced. The supplementary material has been replaced with the corrected version and these errors have been fixed. The original article has been corrected.

AB - In the original publication, the supplementary material was incorrectly formatted prior to publication. The publisher apologises for the errors that were introduced. The supplementary material has been replaced with the corrected version and these errors have been fixed. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85160635302&partnerID=8YFLogxK

U2 - 10.1007/s13555-023-00934-y

DO - 10.1007/s13555-023-00934-y

M3 - Comment/debate

AN - SCOPUS:85160635302

SN - 2190-9172

VL - 13

SP - 1389

EP - 1390

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 6

ER -

Gisondi P, Gottlieb AB, Elewski B, Augustin M, McBride S, Tsai TF et al. Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) (Dermatology and Therapy, (2023), 13, 1, (315-328), 10.1007/s13555-022-00861-4). Dermatology and Therapy. 2023 Jun;13(6):1389-1390. doi: 10.1007/s13555-023-00934-y